Generation Bio Co. operates as a biotechnology company. The Company engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases. Generation Bio serves customers in the United States.
Market Cap | 399.008 Million | Shares Outstanding | 57.001 Million | Avg 30-day Volume | 463.659 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | -1.01 |
Price to Revenue | 0.0 | Debt to Equity | 0.0 | EBITDA | -114.04 Million |
Price to Book Value | 1.0441 | Operating Margin | 0.0 | Enterprise Value | 23.426 Million |
Current Ratio | 20.161 | EPS Growth | 0.281 | Quick Ratio | 19.946 |
1 Yr BETA | 1.8822 | 52-week High/Low | 28.67 / 3.96 | Profit Margin | 0.0 |
Operating Cash Flow Growth | -30.9073 | Altman Z-Score | 1.6945 | Free Cash Flow to Firm | -84.286 Million |
Earnings Report | 2022-08-04 |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
19,200 | 2022-06-09 | 1 | |
|
19,200 | 2022-06-09 | 1 | |
|
19,200 | 2022-06-09 | 1 | |
|
19,200 | 2022-06-09 | 2 | |
|
19,200 | 2022-06-09 | 3 | |
|
19,200 | 2022-06-09 | 1 | |
|
19,200 | 2022-06-09 | 1 | |
|
19,200 | 2022-06-09 | 2 | |
PAONE ANTOINETTE CHIEF OPERATING OFFICER |
|
110,000 | 2022-02-10 | 2 |
MCDONOUGH GEOFF PRESIDENT AND CEO |
|
562,500 | 2022-01-21 | 1 |
KERR DOUGLAS CHIEF MEDICAL OFFICER |
|
178,500 | 2022-01-21 | 2 |
STANTON MATTHEW CHIEF SCIENTIFIC OFFICER |
|
178,500 | 2022-01-21 | 6 |
NORKUNAS MATTHEW CHIEF FINANCIAL OFFICER |
|
178,500 | 2022-01-21 | 1 |
ZIMMERMANN TRACY CHIEF DEVELOPMENT OFFICER |
|
178,500 | 2022-01-21 | 1 |
ATLAS VENTURE ASSOCIATES X, L.P. ATLAS VENTURE ASSOCIATES X, LLC |
|
608 | 2021-09-27 | 2 |
|
8,278,876 | 2021-09-17 | 1 | |
ATLAS VENTURE ASSOCIATES X, L.P. ATLAS VENTURE ASSOCIATES X, LLC |
|
31,616 | 2021-06-21 | 2 |
|
9,111,939 | 2021-04-12 | 0 | |
|
9,111,939 | 2021-03-16 | 1 | |
ANGELINO MARK D. CHIEF OPERATING OFFICER |
|
No longer subject to file | 2021-02-05 | 0 |
|
3,837,638 | 2020-06-16 | 0 | |
|
No longer subject to file | 2020-06-16 | 0 | |
ARTAL INTERNATIONAL MANAGEMENT S.A. |
|
No longer subject to file | 2020-06-16 | 0 |
|
3,837,638 | 2020-06-16 | 0 | |
|
No longer subject to file | 2020-06-16 | 0 | |
ATLAS VENTURE ASSOCIATES X, LLC ATLAS VENTURE ASSOCIATES X, L.P. ATLAS VENTURE OPPORTUNITY FUND I, L.P. |
|
12,630,758 | 2020-06-16 | 1 |
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) I L.P. |
|
No longer subject to file | 2020-06-16 | 0 |
DIPALMA STEPHEN J. SEE REMARKS |
|
0 | 2020-06-11 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-06-13 16:06:06 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct | ||||||||||
2022-06-13 16:05:56 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct | ||||||||||
2022-06-13 16:05:50 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct | ||||||||||
2022-06-13 16:05:47 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct | ||||||||||
2022-06-13 16:05:24 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct | ||||||||||
2022-06-13 16:05:38 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct | ||||||||||
2022-06-13 16:05:34 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct | ||||||||||
2022-06-13 16:05:14 -0400 | 2022-06-09 | A | 19,200 | a | 19,200 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
GENERATION BIO CO GBIO | 2022-06-24 22:15:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 21:45:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 21:15:04 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 20:45:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 20:15:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 19:45:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 19:15:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 18:45:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 18:15:04 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 17:45:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 17:15:03 UTC | 1.1348 | 0.4352 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 16:45:03 UTC | 1.1349 | 0.4351 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 16:15:03 UTC | 1.1349 | 0.4351 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 15:45:03 UTC | 1.1349 | 0.4351 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 15:15:03 UTC | 1.1349 | 0.4351 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 14:45:03 UTC | 1.1096 | 0.4604 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 14:15:03 UTC | 1.1096 | 0.4604 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 13:45:03 UTC | 1.1096 | 0.4604 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 13:15:03 UTC | 1.1096 | 0.4604 | 550000 |
GENERATION BIO CO GBIO | 2022-06-24 12:45:03 UTC | 1.1096 | 0.4604 | 550000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund | GBIO | -2100.0 shares, $-52647.0 | 2021-09-30 | N-PORT |
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio | GBIO | -26300.0 shares, $-659341.0 | 2021-09-30 | N-PORT |